99 related articles for article (PubMed ID: 26527314)
1. The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour.
Farrugia BL; Melrose J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762403
[TBL] [Abstract][Full Text] [Related]
2. Prolonged use of temozolomide leads to increased anxiety and decreased content of aggrecan and chondroitin sulfate in brain tissues of aged rats.
Strokotova AV; Sokolov DK; Molodykh OP; Koldysheva EV; Kliver EE; Ushakov VS; Politko MO; Mikhnevich NV; Kazanskaya GM; Aidagulova SV; Grigorieva EV
Biomed Rep; 2024 Jan; 20(1):7. PubMed ID: 38124768
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycans as potential biomarkers in odontogenic tumors.
Gómez-Herrera Z; Molina-Frechero N; Damián-Matsumura P; Bologna-Molina R
J Oral Maxillofac Pathol; 2018; 22(1):98-103. PubMed ID: 29731564
[TBL] [Abstract][Full Text] [Related]
4. The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle.
Hjorth M; Norheim F; Meen AJ; Pourteymour S; Lee S; Holen T; Jensen J; Birkeland KI; Martinov VN; Langleite TM; Eckardt K; Drevon CA; Kolset SO
Physiol Rep; 2015 Aug; 3(8):. PubMed ID: 26290530
[TBL] [Abstract][Full Text] [Related]
5. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
6. Identification of Epstein-Barr Virus Replication Proteins in Burkitt's Lymphoma Cells.
Traylen C; Ramasubramanyan S; Zuo J; Rowe M; Almohammad R; Heesom K; Sweet SM; Matthews DA; Sinclair AJ
Pathogens; 2015 Oct; 4(4):739-51. PubMed ID: 26529022
[TBL] [Abstract][Full Text] [Related]
7. Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.
Pujals A; Favre L; Pioche-Durieu C; Robert A; Meurice G; Le Gentil M; Chelouah S; Martin-Garcia N; Le Cam E; Guettier C; Raphaël M; Vassilev LT; Gaulard P; Codogno P; Lipinski M; Wiels J
Autophagy; 2015; 11(12):2275-87. PubMed ID: 26565591
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
Liu X; Cohen JI
J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
[TBL] [Abstract][Full Text] [Related]
9. Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children.
Reynaldi A; Schlub TE; Chelimo K; Sumba PO; Piriou E; Ogolla S; Moormann AM; Rochford R; Davenport MP
J Infect Dis; 2016 Mar; 213(6):985-91. PubMed ID: 26531246
[TBL] [Abstract][Full Text] [Related]
10. Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity.
Adiguzel Y; Mahroum N; Muller S; Blank M; Halpert G; Shoenfeld Y
Clin Rev Allergy Immunol; 2023 Aug; 65(2):206-230. PubMed ID: 37505416
[TBL] [Abstract][Full Text] [Related]
11. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.
Oliveira T; Zhang M; Joo EJ; Abdel-Azim H; Chen CW; Yang L; Chou CH; Qin X; Chen J; Alagesan K; Almeida A; Jacob F; Packer NH; von Itzstein M; Heisterkamp N; Kolarich D
Theranostics; 2021; 11(19):9519-9537. PubMed ID: 34646384
[TBL] [Abstract][Full Text] [Related]
12. Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity.
Papadas A; Arauz G; Cicala A; Wiesner J; Asimakopoulos F
J Histochem Cytochem; 2020 Dec; 68(12):871-885. PubMed ID: 32623942
[TBL] [Abstract][Full Text] [Related]
13. Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development.
Kaltenbach DD; Jaishankar D; Hao M; Beer JC; Volin MV; Desai UR; Tiwari V
Front Pharmacol; 2018; 9():1315. PubMed ID: 30555321
[TBL] [Abstract][Full Text] [Related]
14. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
[TBL] [Abstract][Full Text] [Related]
15. Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration.
Agerbaek MØ; Pereira MA; Clausen TM; Pehrson C; Oo HZ; Spliid C; Rich JR; Fung V; Nkrumah F; Neequaye J; Biggar RJ; Reynolds SJ; Tosato G; Pullarkat ST; Ayers LW; Theander TG; Daugaard M; Bhatia K; Nielsen MA; Mbulaiteye SM; Salanti A
Int J Cancer; 2017 Apr; 140(7):1597-1608. PubMed ID: 27997697
[TBL] [Abstract][Full Text] [Related]
16. Serglycin in Quiescent and Proliferating Primary Endothelial Cells.
Reine TM; Vuong TT; Rutkovskiy A; Meen AJ; Vaage J; Jenssen TG; Kolset SO
PLoS One; 2015; 10(12):e0145584. PubMed ID: 26694746
[TBL] [Abstract][Full Text] [Related]
17. Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.
Tsidulko AY; Matskova L; Astakhova LA; Ernberg I; Grigorieva EV
Oncotarget; 2015 Dec; 6(41):43529-39. PubMed ID: 26527314
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
19. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
